Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers

results from the 2010 LIVESTRONG survey

John E. Schmidt, Ellen Beckjord, Dana H. Bovbjerg, Carissa A. Low, Donna M. Posluszny, Amy Elizabeth Allison, Mary Amanda Dew, Stephanie Nutt, Sarah R. Arvey, Ruth Rechis

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose: With cancer survivors now numbering over 13 million in the United States, and expected to continue to increase, it is important to consider the needs of this growing population. In the literature, one of the most common complaints by cancer survivors is perceived cognitive dysfunction. Since the preponderance of the research has focused on breast cancer survivors, the purpose of the present study was to explore the prevalence and correlates of perceived cognitive dysfunction in a large sample of cancer survivors with representation across a wide range of different types of cancer. Methods: A sample of 3108 post-treatment cancer survivors completed the 2010 LIVESTRONG survey as part of a larger study of cancer survivorship. Respondents completed standardized questions regarding current and past perceived cognitive dysfunction, as well as depressive symptoms, and demographic and medical variables. Results: Current perceived cognitive dysfunction was reported by nearly half of respondents (45.7 %), across a wide range of cancer types, with the highest prevalence among survivors of central nervous system cancers. Receiving chemotherapy and current report of depressive symptoms were both strongly associated with current perceived cognitive dysfunction. Conclusion: These findings contribute to a growing appreciation of the high prevalence of perceived cognitive dysfunction in survivors of a wide range of cancer types and the potential interactive effect of concurrent symptoms of depression. These findings highlight a need to develop more effective means of preventing or reducing cognitive dysfunction in cancer survivors. Implications for Cancer Survivors: Perceived cognitive dysfunction was reported in a wide range of cancer survivors. The potential interactive effect of symptoms of depression suggests the need to develop interventions targeting both cognitive dysfunction and depression to achieve improvements in cognitive functioning.

Original languageEnglish (US)
Pages (from-to)302-311
Number of pages10
JournalJournal of Cancer Survivorship
Volume10
Issue number2
DOIs
StatePublished - Apr 1 2016
Externally publishedYes

Fingerprint

Survivors
Neoplasms
Depression
Cognitive Dysfunction
Surveys and Questionnaires
Neurobehavioral Manifestations
Survival Rate
Central Nervous System
Demography
Breast Neoplasms
Drug Therapy

Keywords

  • Chemo-brain
  • Depression
  • LIVESTRONG
  • Perceived cognitive dysfunction
  • Survivors

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)

Cite this

Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers : results from the 2010 LIVESTRONG survey. / Schmidt, John E.; Beckjord, Ellen; Bovbjerg, Dana H.; Low, Carissa A.; Posluszny, Donna M.; Allison, Amy Elizabeth; Dew, Mary Amanda; Nutt, Stephanie; Arvey, Sarah R.; Rechis, Ruth.

In: Journal of Cancer Survivorship, Vol. 10, No. 2, 01.04.2016, p. 302-311.

Research output: Contribution to journalArticle

Schmidt, JE, Beckjord, E, Bovbjerg, DH, Low, CA, Posluszny, DM, Allison, AE, Dew, MA, Nutt, S, Arvey, SR & Rechis, R 2016, 'Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey', Journal of Cancer Survivorship, vol. 10, no. 2, pp. 302-311. https://doi.org/10.1007/s11764-015-0476-5
Schmidt, John E. ; Beckjord, Ellen ; Bovbjerg, Dana H. ; Low, Carissa A. ; Posluszny, Donna M. ; Allison, Amy Elizabeth ; Dew, Mary Amanda ; Nutt, Stephanie ; Arvey, Sarah R. ; Rechis, Ruth. / Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers : results from the 2010 LIVESTRONG survey. In: Journal of Cancer Survivorship. 2016 ; Vol. 10, No. 2. pp. 302-311.
@article{2c30e02c13694d8b83f99aac35473f23,
title = "Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey",
abstract = "Purpose: With cancer survivors now numbering over 13 million in the United States, and expected to continue to increase, it is important to consider the needs of this growing population. In the literature, one of the most common complaints by cancer survivors is perceived cognitive dysfunction. Since the preponderance of the research has focused on breast cancer survivors, the purpose of the present study was to explore the prevalence and correlates of perceived cognitive dysfunction in a large sample of cancer survivors with representation across a wide range of different types of cancer. Methods: A sample of 3108 post-treatment cancer survivors completed the 2010 LIVESTRONG survey as part of a larger study of cancer survivorship. Respondents completed standardized questions regarding current and past perceived cognitive dysfunction, as well as depressive symptoms, and demographic and medical variables. Results: Current perceived cognitive dysfunction was reported by nearly half of respondents (45.7 {\%}), across a wide range of cancer types, with the highest prevalence among survivors of central nervous system cancers. Receiving chemotherapy and current report of depressive symptoms were both strongly associated with current perceived cognitive dysfunction. Conclusion: These findings contribute to a growing appreciation of the high prevalence of perceived cognitive dysfunction in survivors of a wide range of cancer types and the potential interactive effect of concurrent symptoms of depression. These findings highlight a need to develop more effective means of preventing or reducing cognitive dysfunction in cancer survivors. Implications for Cancer Survivors: Perceived cognitive dysfunction was reported in a wide range of cancer survivors. The potential interactive effect of symptoms of depression suggests the need to develop interventions targeting both cognitive dysfunction and depression to achieve improvements in cognitive functioning.",
keywords = "Chemo-brain, Depression, LIVESTRONG, Perceived cognitive dysfunction, Survivors",
author = "Schmidt, {John E.} and Ellen Beckjord and Bovbjerg, {Dana H.} and Low, {Carissa A.} and Posluszny, {Donna M.} and Allison, {Amy Elizabeth} and Dew, {Mary Amanda} and Stephanie Nutt and Arvey, {Sarah R.} and Ruth Rechis",
year = "2016",
month = "4",
day = "1",
doi = "10.1007/s11764-015-0476-5",
language = "English (US)",
volume = "10",
pages = "302--311",
journal = "Journal of Cancer Survivorship",
issn = "1932-2259",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers

T2 - results from the 2010 LIVESTRONG survey

AU - Schmidt, John E.

AU - Beckjord, Ellen

AU - Bovbjerg, Dana H.

AU - Low, Carissa A.

AU - Posluszny, Donna M.

AU - Allison, Amy Elizabeth

AU - Dew, Mary Amanda

AU - Nutt, Stephanie

AU - Arvey, Sarah R.

AU - Rechis, Ruth

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Purpose: With cancer survivors now numbering over 13 million in the United States, and expected to continue to increase, it is important to consider the needs of this growing population. In the literature, one of the most common complaints by cancer survivors is perceived cognitive dysfunction. Since the preponderance of the research has focused on breast cancer survivors, the purpose of the present study was to explore the prevalence and correlates of perceived cognitive dysfunction in a large sample of cancer survivors with representation across a wide range of different types of cancer. Methods: A sample of 3108 post-treatment cancer survivors completed the 2010 LIVESTRONG survey as part of a larger study of cancer survivorship. Respondents completed standardized questions regarding current and past perceived cognitive dysfunction, as well as depressive symptoms, and demographic and medical variables. Results: Current perceived cognitive dysfunction was reported by nearly half of respondents (45.7 %), across a wide range of cancer types, with the highest prevalence among survivors of central nervous system cancers. Receiving chemotherapy and current report of depressive symptoms were both strongly associated with current perceived cognitive dysfunction. Conclusion: These findings contribute to a growing appreciation of the high prevalence of perceived cognitive dysfunction in survivors of a wide range of cancer types and the potential interactive effect of concurrent symptoms of depression. These findings highlight a need to develop more effective means of preventing or reducing cognitive dysfunction in cancer survivors. Implications for Cancer Survivors: Perceived cognitive dysfunction was reported in a wide range of cancer survivors. The potential interactive effect of symptoms of depression suggests the need to develop interventions targeting both cognitive dysfunction and depression to achieve improvements in cognitive functioning.

AB - Purpose: With cancer survivors now numbering over 13 million in the United States, and expected to continue to increase, it is important to consider the needs of this growing population. In the literature, one of the most common complaints by cancer survivors is perceived cognitive dysfunction. Since the preponderance of the research has focused on breast cancer survivors, the purpose of the present study was to explore the prevalence and correlates of perceived cognitive dysfunction in a large sample of cancer survivors with representation across a wide range of different types of cancer. Methods: A sample of 3108 post-treatment cancer survivors completed the 2010 LIVESTRONG survey as part of a larger study of cancer survivorship. Respondents completed standardized questions regarding current and past perceived cognitive dysfunction, as well as depressive symptoms, and demographic and medical variables. Results: Current perceived cognitive dysfunction was reported by nearly half of respondents (45.7 %), across a wide range of cancer types, with the highest prevalence among survivors of central nervous system cancers. Receiving chemotherapy and current report of depressive symptoms were both strongly associated with current perceived cognitive dysfunction. Conclusion: These findings contribute to a growing appreciation of the high prevalence of perceived cognitive dysfunction in survivors of a wide range of cancer types and the potential interactive effect of concurrent symptoms of depression. These findings highlight a need to develop more effective means of preventing or reducing cognitive dysfunction in cancer survivors. Implications for Cancer Survivors: Perceived cognitive dysfunction was reported in a wide range of cancer survivors. The potential interactive effect of symptoms of depression suggests the need to develop interventions targeting both cognitive dysfunction and depression to achieve improvements in cognitive functioning.

KW - Chemo-brain

KW - Depression

KW - LIVESTRONG

KW - Perceived cognitive dysfunction

KW - Survivors

UR - http://www.scopus.com/inward/record.url?scp=84938629372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938629372&partnerID=8YFLogxK

U2 - 10.1007/s11764-015-0476-5

DO - 10.1007/s11764-015-0476-5

M3 - Article

VL - 10

SP - 302

EP - 311

JO - Journal of Cancer Survivorship

JF - Journal of Cancer Survivorship

SN - 1932-2259

IS - 2

ER -